Sphere Fluidics

Sphere Fluidics is a Cambridge, UK-based Life Sciences R&D company that specializes in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, and analysis and isolation. The company is reported to own 25 patented products that include instruments, biochips, and specialist chemicals.[1][2]

Overview

Sphere Fluidics was originally established in 2010, with two chemistry professors of Cambridge University, namely, Professor Chris Abell and Professor Wilhelm Huck, Dr. Frank F. Craig, an entrepreneur, and Dr. Maher Khaled, a Cambridge University Enterprise, as founders.[1][3][4]

Funding

The total funds raised by Sphere Fluidics as of 2017, is reported to be, $13 million through various funding rounds and grants.[3][2][4]

Cyto-Mine Technology

Cyto-Mine is a patented single cell analysis and characterisation system by Sphere Fluidics. This technology is said to aid the development of biotherapeutics for treatment of cancer and inflammatory diseases and vaccine generation. Cyto-Mine is said to be an integrated device which can automatically perform single cell analysis, sorting, imaging and dispensing into individual wells of microtiter plates in a single compact system.[5][6][3]

Awards

2013 : ACES Life Science Award[7][4]

2015: UK's top 50 disruptive SMEs by Real Business[8][9]

2017: European Product Innovation Award[1][10]

gollark: ++fortune
gollark: Ohhh.
gollark: ++help
gollark: ++fortune
gollark: ++exec```hs(^∆) x y = 2 + x `div` y + (x * y * (-y))main = print $ 1 ^∆ 3```

References
  1. "Triple success for Cambridge life science pioneers | Business Weekly | Technology News | Business news | Cambridge and the East of England". www.businessweekly.co.uk. Retrieved 2017-12-11.
  2. site., Who made this. "Sphere Fluidics wins $7 million for development of single cell analysis system - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-12-11.
  3. "Sphere Fluidics: biotherapeutics device attracts $7m investment - GOV.UK". www.gov.uk. Retrieved 2017-12-11.
  4. "Re-inventing the test tube: Sphere Fluidics pioneers new approach to analysing cell samples | Science|Business". sciencebusiness.net. Retrieved 2017-12-11.
  5. "Sphere Fluidics, Geneva Biotech Receive €1.6M Grant to Develop DNA Cargo Delivery System". GenomeWeb. Retrieved 2017-12-11.
  6. "TTP Plc and Sphere Fluidics introduce Cyto-Mine Single Cell Analysis System". The Scientist. Retrieved 2017-12-11.
  7. "Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online". www.labmate-online.com. Retrieved 2017-12-11.
  8. site., Who made this. "Sphere Fluidics named one of Britain's most disruptive businesses - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-12-11.
  9. "Future 50 retrospective: Innovating big for the future". Real Business. 2017-02-28. Retrieved 2017-12-11.
  10. "Frost & Sullivan Commends Sphere Fluidics for Its Innovative Single-cell Analysis Platform Solution".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.